Network based consensus gene signatures for biomarker discovery in breast cancer

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Fröhlich, Holger ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALVESPIMYCIN; CIPROFLOXACIN; ERIBULIN; ERLOTINIB; ESORUBICIN; ESTRAMUSTINE; GEFITINIB; INDISULAM; PACLITAXEL; PERTUZUMAB; RETASPIMYCIN; TANESPIMYCIN; TRASTUZUMAB; TUMOR MARKER;

ARTICLE; BREAST CANCER; CDK2 GENE; CONSENSUS GENE SIGNATURE; CONTROLLED STUDY; DRUG TARGETING; EGFR GENE; ERBB2 GENE; GENE EXPRESSION PROFILING; GENE MAPPING; GENE REGULATORY NETWORK; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC PARAMETERS; GENETIC STABILITY; HSP90AA1 GENE; MICROARRAY ANALYSIS; PREDICTIVE VALUE; PROTEIN INTERACTION; TOP2A GENE; TUB4A1A GENE; TUBA1B GENE; ALGORITHM; BIOLOGY; BREAST TUMOR; FEMALE; GENETICS; HUMAN; METHODOLOGY; PROTEIN PROTEIN INTERACTION;

ALGORITHMS; BREAST NEOPLASMS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; FEMALE; GENE EXPRESSION PROFILING; HUMANS; PROTEIN INTERACTION MAPS; TUMOR MARKERS, BIOLOGICAL;

EID: 84858791095     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025364     Document Type: Article

References (37)

1. Meyer JM, Ginsburg GS, (2002) The path to personalized medicine. Curr Opin Chem Biol 6: 434-438.
2. Spang R, (2003) Diagnostic signatures from microarrays: a bioinformatics concept for personalized medicine. BIOSILICO 1: 64-68.
3. van't Veer LJ, Bernards R, (2008) Enabling personalized cancer medicine through analysis of geneexpression patterns. Nature 452: 564-570.
4. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
5. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, et al. (2009) Ncbi geo: archive for highthroughput functional genomic data. Nucleic Acids Res 37: D885-D890.
6. Parkinson H, Kapushesky M, Kolesnikov N, Rustici G, Shojatalab M, et al. (2009) Arrayexpress update-from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res 37: D868-D872.
7. Culhane AC, Schwarzl T, Sultana R, Picard KC, Picard SC, et al. (2010) Genesigdb-a curated database of gene expression signatures. Nucleic Acids Res 38: D716-D725.
8. Ein-Dor L, Kela I, Getz G, Givol D, Domany E, (2005) Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 21: 171-178.
9. Yu JX, Sieuwerts AM, Zhang Y, Martens JWM, Smid M, et al. (2007) Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer. BMC Cancer 7: 182.
10. Gönen M, (2009) Statistical aspects of gene signatures and molecular targets. Gastrointest Cancer Res 3: S19-S21.
11. de Bono JS, Ashworth A, (2010) Translating cancer research into targeted therapeutics. Nature 467: 543-549.
12. Sims AH, (2009) Bioinformatics and breast cancer: what can high-throughput genomic approaches actually tell us? J Clin Pathol 62: 879-885.
13. Gong X, Wu R, Zhang Y, Zhao W, Cheng L, et al. (2010) Extracting consistent knowledge from highly inconsistent cancer gene data sources. BMC bioinformatics 11: 76.
14. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, et al. (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463: 318-325.
15. Bertucci F, Houlgatte R, Granjeaud S, Nasser V, Loriod B, et al. (2002) Prognosis of breast cancer and gene expression pro-ling using dna arrays. Ann N Y Acad Sci 975: 217-231.
16. Huang E, Cheng SH, Dressman H, Pittman J, Tsou MH, et al. (2003) Gene expression predictors of breast cancer outcomes. Lancet 361: 1590-1596.
17. Li LF, Xu XJ, Zhao Y, Liu ZB, Shen ZZ, et al. (2009) Integrated gene expression profile predicts prognosis of breast cancer patients. Breast Cancer Res Treat 113: 231-237.
18. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AAM, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
19. Wang Y, Klijn JGM, Zhang Y, Sieuwerts AM, Look MP, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.
20. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, et al. (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98: 262-272.
21. Ivshina AV, George J, Senko O, Mow B, Putti TC, et al. (2006) Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 66: 10292-10301.
22. Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, et al. (2008) The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 68: 5405-5413.
23. Pawitan Y, Bjöhle J, Amler L, Borg AL, Egyhazi S, et al. (2005) Gene expression pro-ling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 7: R953-R964.
24. Cerami EG, Gross BE, Demir E, Rodchenkov I, Babur O, et al. (2011) Pathway commons, a web resource for biological pathway data. Nucleic Acids Res 39: D685-D690.
25. Osborne JD, Flatow J, Holko M, Lin SM, Kibbe WA, et al. (2009) Annotating the human genome with disease ontology. BMC Genomics 10 (Suppl 1): S6.
26. Benjamini, Y, Yekutieli, D, (2001) The control of the false discovery rate in multiple testing under dependency. Annals of Statistics 29: 1165-1188.
27. Lin VC, Ng EH, Aw SE, Tan MG, Ng EH, et al. (2000) Progesterone induces focal adhesion in breast cancer cells mda-mb-231 transfected with progesterone receptor complementary dna. Mol Endocrinol 14: 348-358.
28. Xiong B, Li S, Ai JS, Yin S, Ouyang YC, et al. (2008) Brca1 is required for meiotic spindle assembly and spindle assembly checkpoint activation in mouse oocytes. Biol Reprod 79: 718-726.
29. Kretzschmar M, (2000) Transforming growth factor-beta and breast cancer: Transforming growth factor-beta/smad signaling defects and cancer. Breast Cancer Res 2: 107-115.
30. Gasco M, Shami S, Crook T, (2002) The p53 pathway in breast cancer. Breast Cancer Res 4: 70-76.
31. Hochreiter S, Clevert DA, Obermayer K, (2006) A new summarization method for A-ymetrix probe level data. Bioinformatics (Oxford, England) 22: 943-9.
32. Tusher VG, Tibshirani R, Chu G, (2001) Signi-cance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121.
33. Tikhonov A, Arsenin V, (1977) Solutions of ill-posed problems. Washington W.H. Winston & Sons.
34. Kanehisa M, (2008) Kegg for linking genomes to life and the environment. Nucleic Acids Res 36: D480-D484.
35. Zhang JD, Wiemann S, (2009) Kegggraph: a graph approach to kegg pathway in r and bioconductor. Bioinformatics 25: 1470-1471.
36. Jain A, Dubes R, (1988) Algorithms for Clustering Data. Englewood Cliffs, NJ Prentice-Hall.
37. Phipson B, Smyth GK, (2010) Permutation p-values should never be zero: calculating exact p-values when permutations are randomly drawn. Stat Appl Genet Mol Biol 9: Article39.